-
. Find out more about the Lanyon-Hogg group’s research at: https://www.pharm.ox.ac.uk/research/lanyon-hogg-group You should have: Experience in design, synthesis, characterisation of small molecule
-
with a PhD in Engineering (or close to completion) may apply. You will be responsible for: Design of the first reconfigurable robotic matter in collaboration with world-leading universities and
-
generate key structural and biophysical data to support the design of small molecule inhibitors with particular focus on protein production and crystallisation, solving protein-ligand structures, fragment
-
facilely applied as a photoluminescent layer, targeting in situ detection and non-contact visualization of surface temperatures and pressures. You should hold a PhD/DPhil (or near completion*) in materials
-
to real-world actions. This is an exciting opportunity to contribute to foundational work at the intersection of AI safety and autonomous system deployment. You will be responsible for designing experiments
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA
-
AI technologies that will revolutionize how we understand and respond to human behaviour in both real-time and long-term contexts. You will play a crucial role in the testing and design of novel
-
methodology, theory, and applications across the areas of Bayesian experimental design, active learning, probabilistic deep learning, and related topics. The £1.23M project is funded by the UKRI Horizon
-
for a fixed term (funded until 31 March 2026) You will coordinate of survey studies across all partner institutions, including design, delivery and evaluation of a Mental Health Literacy Course and
-
approaches, as well as being able to build on expertise in bacteriology, cell biology, structural biology and biochemistry in the group. You should hold, or be close to completion of, a PhD/DPhil in biological